
News|Articles|December 27, 2024
Top 5 News Articles of 2024
Author(s)MHE Staff
Of the top news articles, Vertex Pharmaceuticals' suzetrigine garnered much attention as it's a promising new class of pain medicine that might offer hope for those struggling with acute pain issues who want to avoid opioids and NSAIDs.
Advertisement
- UnitedHealthcare Adds Deductibles to Medicare Part D for 2025
UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act.Read more - Cataract Surgery: It Is More Than Just Your Vision That Improves
Researchers have identified an association between cataract surgery and a lower risk of cognitive decline and dementia.Read more - NDA Resubmitted for Dry Eye Treatment Reproxalap
Dry eye disease affects up to 15% of the U.S. population and is one of the largest markets in the ophthalmology field.Read here - mRNA Vaccine Momentum
The success of mRNA vaccines against COVID-19 has led to a surge of mRNA vaccines being developed for other diseases.Read here - A New Class of Medicine for Pain Relief on The Horizon
Developed by Vertex Pharmaceuticals, suzetrigine is a promising new class of pain medicine that has been gaining attention for its innovative mechanism of action and reported efficacy; suzetrigine might offer hope for those struggling with acute pain issues who want to avoid opioids and NSAIDs.Read here
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
2
CGM prescribed by primary care lowers A1C and acute care use in diabetes patients
3
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
4
Could uveitis in patients with melanoma being treated with immune checkpoint inhibitors be a good thing?
5


























